Established in 2014, RBV Capital is a venture capital firm located in Zug, Switzerland. They focus on investing in biopharmaceuticals, biomedical technology and services, bioinformatics, healthcare IT, and medical device companies. With a commitment to addressing unmet medical and market needs, RBV Capital seeks out investments with the potential for global impact. For more information, please visit their website at www.rbvcapital.com.